CO5280081A1 - Antibacterianos de piperidiniloxi oxazolidinona, composicion farmaceutica que los comprende y proceso para su preparacion - Google Patents

Antibacterianos de piperidiniloxi oxazolidinona, composicion farmaceutica que los comprende y proceso para su preparacion

Info

Publication number
CO5280081A1
CO5280081A1 CO00097143A CO00097143A CO5280081A1 CO 5280081 A1 CO5280081 A1 CO 5280081A1 CO 00097143 A CO00097143 A CO 00097143A CO 00097143 A CO00097143 A CO 00097143A CO 5280081 A1 CO5280081 A1 CO 5280081A1
Authority
CO
Colombia
Prior art keywords
alkyl
theteroaryl
taryl
chr5r6
jpeg
Prior art date
Application number
CO00097143A
Other languages
English (en)
Spanish (es)
Inventor
Michele Well-Weidner
Christine Boggs
Dennis Hlasta
Eric Nelson
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of CO5280081A1 publication Critical patent/CO5280081A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CO00097143A 1999-12-21 2000-12-21 Antibacterianos de piperidiniloxi oxazolidinona, composicion farmaceutica que los comprende y proceso para su preparacion CO5280081A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17292399P 1999-12-21 1999-12-21
US09/729,342 US6518285B2 (en) 1999-12-21 2000-12-05 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials

Publications (1)

Publication Number Publication Date
CO5280081A1 true CO5280081A1 (es) 2003-05-30

Family

ID=22629768

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00097143A CO5280081A1 (es) 1999-12-21 2000-12-21 Antibacterianos de piperidiniloxi oxazolidinona, composicion farmaceutica que los comprende y proceso para su preparacion

Country Status (17)

Country Link
US (1) US6518285B2 (cg-RX-API-DMAC10.html)
EP (1) EP1246810B1 (cg-RX-API-DMAC10.html)
JP (1) JP2003518106A (cg-RX-API-DMAC10.html)
CN (1) CN1227238C (cg-RX-API-DMAC10.html)
AR (1) AR029420A1 (cg-RX-API-DMAC10.html)
AT (1) ATE326452T1 (cg-RX-API-DMAC10.html)
AU (1) AU784314B2 (cg-RX-API-DMAC10.html)
CA (1) CA2395204C (cg-RX-API-DMAC10.html)
CO (1) CO5280081A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106124T1 (cg-RX-API-DMAC10.html)
DE (1) DE60028085T2 (cg-RX-API-DMAC10.html)
DK (1) DK1246810T3 (cg-RX-API-DMAC10.html)
ES (1) ES2265365T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA02006323A (cg-RX-API-DMAC10.html)
MY (1) MY127677A (cg-RX-API-DMAC10.html)
PT (1) PT1246810E (cg-RX-API-DMAC10.html)
WO (1) WO2001046164A1 (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US6940748B2 (en) 2002-05-16 2005-09-06 Micron Technology, Inc. Stacked 1T-nMTJ MRAM structure
EP1594852A1 (en) * 2003-02-07 2005-11-16 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
MXPA05011654A (es) 2003-04-30 2005-12-15 Morphochem Ag Komb Chemie Uso de antibioticos hibridos de oxazolidinona-quinolina para el tratamiento del antrax y de otras infecciones.
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
ES2310299T5 (es) 2003-12-18 2014-02-10 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibióticos híbridos a base de oxazolidinona-quinolona
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
EP2316458A1 (en) * 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
RU2405770C2 (ru) 2005-09-27 2010-12-10 Сионоги Энд Ко., Лтд. Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
JP5209254B2 (ja) * 2007-08-30 2013-06-12 日本曹達株式会社 置換フェノキシアザビシクロオクタン誘導体の製造方法
CN108785728A (zh) * 2017-05-05 2018-11-13 国家纳米科学中心 含药物中间体修饰的纳米金的抗菌敷料、其制备方法及应用
CN109503569B (zh) * 2019-01-03 2021-01-15 山东大学 噻唑类衍生物及其制备方法和应用
EP4416140A1 (en) * 2021-10-12 2024-08-21 F. Hoffmann-La Roche AG Sulfonylpiperazinyl compounds for treatment of bacterial infections
AR127435A1 (es) * 2021-10-26 2024-01-24 Hoffmann La Roche Compuestos piperazinilsulfonilarilo para el tratamiento de infecciones bacterianas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
JPS608277A (ja) * 1983-06-07 1985-01-17 ザ・デュポン・メルク・ファーマシュウティカル・カンパニー アミノメチルオキソオキサゾリジニルベンゼン誘導体
ES533097A0 (es) 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
BR9509673A (pt) 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
DK0807112T3 (da) 1995-02-03 2001-12-17 Upjohn Co Antimikrobiel heteroaromatisk ringsubstitueret phenyloxazolidinon
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
US6090820A (en) 1995-05-11 2000-07-18 Pharmacia & Upjohn Company Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
US5883093A (en) 1995-09-12 1999-03-16 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
SG85683A1 (en) 1996-04-11 2002-01-15 Upjohn Co Process to prepare oxazolidinones
FI19992555A7 (fi) 1997-05-30 1999-11-30 Upjohn Co Antibakteerisia oksatosolidinoniaineita, joilla on tiokarbonyylifunktionaalisuus
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
AU9001598A (en) 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
JP2000204084A (ja) * 1998-11-11 2000-07-25 Hokuriku Seiyaku Co Ltd チオカルバミド酸誘導体

Also Published As

Publication number Publication date
CN1227238C (zh) 2005-11-16
PT1246810E (pt) 2006-08-31
MY127677A (en) 2006-12-29
US20020103377A1 (en) 2002-08-01
ATE326452T1 (de) 2006-06-15
AU2261701A (en) 2001-07-03
DE60028085D1 (de) 2006-06-22
AU784314B2 (en) 2006-03-09
WO2001046164A1 (en) 2001-06-28
ES2265365T3 (es) 2007-02-16
EP1246810A1 (en) 2002-10-09
MXPA02006323A (es) 2003-09-22
DE60028085T2 (de) 2006-12-07
US6518285B2 (en) 2003-02-11
CY1106124T1 (el) 2011-06-08
CA2395204A1 (en) 2001-06-28
JP2003518106A (ja) 2003-06-03
DK1246810T3 (da) 2006-09-18
CA2395204C (en) 2008-02-05
CN1434810A (zh) 2003-08-06
AR029420A1 (es) 2003-06-25
EP1246810B1 (en) 2006-05-17

Similar Documents

Publication Publication Date Title
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
CO5150176A1 (es) Antagonistas iii del receptor ccr-3 de los receptores ccr-3 composicio farmaceutica que los con- tiene y procedimiento para la preparacion de estos compues- tos.
EE05126B1 (et) Trifenlalkeeni derivaadid ja nende kasutamine selektiivsete ”strogeeniretseptorite modulaatoritena
EA200000334A1 (ru) Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
AR035689A1 (es) Diarilureas sustituidas, composiciones farmaceuticas que las comprenden, usos de dichos compuestos y procesos para la preparacion de dichos compuestos
AR004219A1 (es) Nuevos derivados de quinazolina, procedimientos para su preparacion, composiciones que los contienen y su uso en la preparacion de medicamentos,particularmente en el tratamiento de trastornos inflamatorios
AR012244A1 (es) Compuestos derivados de la 9-oxima eritomicina, composicion farmaceutica que los contiene, procedimiento para el tratamiento de una infeccion bacterianao protozoaria, procedimiento para su preparacion.
KR950011444A (ko) 갈란타민 유도체, 이의 제조방법 및 약제로서의 이의 용도
CO5200758A1 (es) Derivados de 1,5-dihidropirrol-2-ona sustituida, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estos compuestos para la preparacion de medicamentos
DE58904143D1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
EA199800987A1 (ru) Бензоксазиноновые антагонисты рецептора допамина d4
ES2059828T3 (es) Un procedimiento para la preparacion de un compuesto.
AR031197A1 (es) Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta(b) diazepino(6,7,1-hi)indol
MY113518A (en) Benzothiazolone derivatives
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
NZ506853A (en) C11 oxymyl and hydroxylamino prostaglandins (PGF) analogs useful as medicaments
CO4700282A1 (es) Compuestos
EA199600007A2 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
AR004675A1 (es) Nuevos compuestos antagonistas de receptores de endotelina, procedimiento para prepararlos, composiciones farmaceuticas que los contienen yprocedimiento para preparar estas composiciones farmaceuticas.
NO308851B1 (no) Fusjonerte indol- og kinoksalderivater, farmasøytisk blanding og anvendelse av forbindelsen
ES8304122A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
NZ506855A (en) C11 Oxymyl and hydroxylamino prostaglandins useful as FP agonists
AR028818A1 (es) Pirido-tieno-diazepinas, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que las contienen y compuestos intermediarios utilizados en dicho procedimiento
CO5261489A1 (es) Bases pirrolicas sustituidas de mannich, procedimiento para su preparacion, medicamentos que contienen estos compuestos, y uso del compuesto para la preparacion de medicamentos

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed